This study demonstrates that the FnCas9 system can be programmed as an antiviral defense to target and inhibit viral RNA in eukaryotic cells.
Answers are grounded in this paper and cite their sources.
Supports CRISPR antivirals for RNA viruses in cells; leaves open in vivo efficacy and clinical translation.
Clustered, regularly interspaced, short palindromic repeats-CRISPR associated (CRISPR-Cas) systems are prokaryotic RNA-directed endonuclease machineries that act as an adaptive immune system against foreign genetic elements. Using small CRISPR RNAs that provide specificity, Cas proteins recognize and degrade nucleic acids. Our previous work demonstrated that the Cas9 endonuclease from Francisella novicida (FnCas9) is capable of targeting endogenous bacterial RNA. Here, we show that FnCas9 can be directed by an engineered RNA-targeting guide RNA to target and inhibit a human +ssRNA virus, hepatitis C virus, within eukaryotic cells. This work reveals a versatile and portable RNA-targeting system that can effectively function in eukaryotic cells and be programmed as an antiviral defense.
No takes yet. Share an insight, caveat, or question.
Price et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: